Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 21

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 21
---
 direct or indirect business relationships with us or any of our subsidiaries. The Organization and Compensation Committee evaluated whether any work provided by Aon raised any conflict of interest for services performed during fiscal 2024 and determined that it did not. Additionally, during fiscal 2024, Aon conducted a pay equity analysis and provided a compensation database to the Company. COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION During the 2024 fiscal year, the directors who served on our Organization and Compensation Committee were Ms. Broader, Ms. Burks, and Mr. Tansey, none of whom was, during the fiscal year, an officer or employee of the Company and none of whom was formerly an officer of the Company. During fiscal 2024, none of our executive officers served as a member of the board of directors or compensation committee (or other committee performing equivalent functions) of any entity that had one or more executive officers serving on our Board or Organization and Compensation Committee. During fiscal 2024, no other relationships required to be disclosed by the rules of the SEC existed aside from those identified herein. Nominating and Corporate Governance Committee Our Nominating and Corporate Governance Committee oversees and assists our Board in reviewing and recommending nominees for election as directors. Our Nominating and Corporate Governance Committee is responsible for, among other things:

| • | identifying individuals qualified to become members of our Board, consistent with criteria approved by our Board of Directors; |

| • | recommending to our Board the nominees for election to our Board at annual meetings of our stockholders; |

| • | overseeing the Company’s strategy, policies, and practices and related reporting with respect to significant sustainability matters, in coordination with other Board committees; |

| Inspire Medical Systems, Inc. |     | 19 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

| CORPORATE GOVERNANCE |

| • | overseeing the annual self-evaluations of our Board and management, together with our Lead Director; |

| • | reviewing the Company’s succession plans for its Chief Executive Officer; and |

| • | developing and recommending to our Board a set of corporate governance guidelines and principles. |

The Nominating and Corporate Governance Committee may delegate its authority under its charter to one or more subcommittees as it deems appropriate from time to time. The Nominating and Corporate Governance Committee has the authority to retain any search firm to be used to identify director nominees and independent legal and other advisors as it deems necessary or appropriate to carry out its responsibilities and